Sexual medicine

'Blue balls': There’s no evidence they’re harmful, and they shouldn’t be used to pressure partners into sex

Retrieved on: 
Friday, June 2, 2023

Most people — health-care providers included — are familiar with this term referring to scrotal discomfort experienced in response to prolonged sexual arousal without orgasm.

Key Points: 
  • Most people — health-care providers included — are familiar with this term referring to scrotal discomfort experienced in response to prolonged sexual arousal without orgasm.
  • Although no one knows how the pain of blue balls develops, most implicate the slowed drainage of blood from the testicles in the absence of orgasm during sexual arousal.
  • One of the key physiological aspects of sexual arousal is increased blood flow to areas of the body, including the genitals.

Anyone can get ‘blue balls’

    • Let’s first clarify a major issue assumed by the term “blue balls” related to who can experience this phenomenon, based on the results of this study.
    • The term assumes that discomfort resulting from sexual arousal without orgasm only exists in “balls,” referring to the scrotum.
    • This is consistent with the lack of medical research and clinical attention to this topic.

Concerns about coercion

    • Pressure to engage in sexual activity is sexual coercion, which is associated with negative outcomes in terms of health and well-being, such as increased risk of depression and anxiety, low self-esteem and negative sexual self-perceptions.
    • Sexual activity in response to coercion certainly does not conform to enthusiastic and freely given sexual consent.
    • A recent discussion about sexual coercion in response to “blue balls” gained much attention in response to a TikTok, which has since been deleted.

Gendered expectations

    • It will take effort to change ideas related to sexual expectations in our society, many of which are gendered.
    • The traditional sexual script — guidelines for “appropriate” sexual behaviour in heterosexual couples (for example, the “steps” to sexual intercourse, such as kissing and genital touching) — emphasizes heterosexual men’s pleasure.
    • Sexual coercion in response to pain due to sexual activity without orgasm, is another example.

Aspargo’s Global Footprint Grows With Middle East Expansion, Disrupting the Erectile Dysfunction Market With Oral Spray

Retrieved on: 
Tuesday, October 4, 2022

Taiba will assume responsibility for and bear the cost of obtaining regulatory approval to market Sildenafil Spray in each jurisdiction in the Territory.

Key Points: 
  • Taiba will assume responsibility for and bear the cost of obtaining regulatory approval to market Sildenafil Spray in each jurisdiction in the Territory.
  • Farmalider, the licensor to Aspargo of the rights to Sildenafil Spray and manufacturer of Sildenafil Spray for Aspargo in Spain and Mexico, will manufacture and package Sildenafil Spray for resale in the Territory.
  • Aspargos pocket-sized oral spray empowers men to manage their erectile dysfunction in a discreet way, and were proud of this next phase in our global expansion efforts.
  • Aspargos current focus is to commercialize an oral spray formulation of sildenafil citrate, the active ingredient in Viagra.

Aspargo Expands Beyond Spain Into Latin America, Disrupting Erectile Dysfunction (ED) Market With Oral Spray

Retrieved on: 
Tuesday, June 21, 2022

The Agreements allow Aspargo to expand its international marketing of Sildenafil Oral Spray for the treatment of erectile dysfunction to the Latin American market.

Key Points: 
  • The Agreements allow Aspargo to expand its international marketing of Sildenafil Oral Spray for the treatment of erectile dysfunction to the Latin American market.
  • Sildenafil Oral Spray is an oral liquid suspension of sildenafil citrate administered via a spray pump that dispenses 12.5 mg of sildenafil per push.
  • Farmalider, S.A. (Madrid, Spain), licensor to Aspargo of the patent rights to Sildenafil Oral Spray, will supply the commercial product for the Spanish market pursuant to a multi-year Supply Agreement.
  • Aspargo is the US and international licensee of the patent rights covering Sildenafil Oral Spray from Farmalider, S.A. of Madrid, Spain (www.farmalider.com).

Aspargo Acquires Bandol® Sildenafil Spray, Currently Marketed In Spain

Retrieved on: 
Wednesday, May 4, 2022

ENGLEWOOD CLIFFS, N.J. and BARCELONA, Spain, May 04, 2022 (GLOBE NEWSWIRE) -- Aspargo Laboratories, Inc., a privately held specialty pharmaceutical company focused on commercializing innovative formulations of leading medications, today announced the acquisition of the prescription brand BANDOL® (sildenafil oral suspension) from Laboratorios Rubio S.A., a specialty pharmaceutical company headquartered in Barcelona, Spain. BANDOL® is indicated for the treatment of erectile dysfunction (ED). Concurrent with the acquisition, Aspargo entered into a distribution agreement with Rubio for the continued marketing and promotion of BANDOL® in Spain and a license and supply agreement with Farmalider, S.A. (Madrid, Spain) for the supply of BANDOL® to the Spanish market.

Key Points: 
  • Concurrent with the acquisition, Aspargo entered into a distribution agreement with Rubio for the continued marketing and promotion of BANDOL in Spain and a license and supply agreement with Farmalider, S.A. (Madrid, Spain) for the supply of BANDOL to the Spanish market.
  • Utilizing BANDOL as our initial venture in Europe, we plan to accelerate the commercialization of Sildenafil Oral Spray in other European countries and globally, subject to regulatory compliance in each country.
  • Aspargos current focus is to commercialize an oral spray formulation of sildenafil citrate, the active ingredient in VIAGRA.
  • Aspargo is the US and international licensee of the patent rights covering Sildenafil Oral Spray from Farmalider, S.A. of Madrid, Spain (www.farmalider.com).

Dr. Melissa (Mel) Irvine Invites People To Celebrate Sexual Health Month with Self Care

Retrieved on: 
Tuesday, October 12, 2021

FORT MYERS, Fla., Oct. 12, 2021 /PRNewswire-PRWeb/ -- Whether you're single or in a relationship, it's important to celebrate September as Sexual Health Month by taking care of yourself.

Key Points: 
  • FORT MYERS, Fla., Oct. 12, 2021 /PRNewswire-PRWeb/ -- Whether you're single or in a relationship, it's important to celebrate September as Sexual Health Month by taking care of yourself.
  • "And actually, the challenges they're facing are often simpler than they think, and we work together to get them resolved."
  • Dr. Mel sees patients of all genders but feels it's especially important for women to understand their bodies and address their sexual health.
  • As a Sexual Medicine provider, she takes pride in providing high-quality personalized care to meet the sexual health needs of both men and women.

Raising Awareness of Premature Ejaculation, Morari Medical Introduces Wearable Prototype at CES

Retrieved on: 
Monday, January 6, 2020

The company also announced a partnership with San Diego Sexual Medicine to conduct a study of the wearable solution.

Key Points: 
  • The company also announced a partnership with San Diego Sexual Medicine to conduct a study of the wearable solution.
  • "PE is the number one male sexual dysfunction, yet most men don't want to talk about it," said Bennett, founder of Morari Medical.
  • "The use of neuromodulation is a common modality that has been proven to treat a variety of different medical conditions.
  • The Morari team is leveraging its 75 years of collective experience in urology and sexual health to develop a wearable device-based treatment for premature ejaculation (PE).